| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,437 |
2,076 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
365 |
306 |
$189.22 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,921 |
1,668 |
$97.08 |
| 86703 |
|
464 |
464 |
$0.00 |
| 82274 |
|
352 |
352 |
$0.00 |
| 82540 |
|
387 |
379 |
$0.00 |
| 80061 |
Lipid panel |
2,218 |
2,198 |
$0.00 |
| 99442 |
|
427 |
408 |
$0.00 |
| 84450 |
|
175 |
174 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
41 |
40 |
$0.00 |
| 3077F |
|
139 |
136 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
234 |
114 |
$0.00 |
| 84460 |
|
349 |
347 |
$0.00 |
| 3078F |
|
826 |
755 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$0.00 |
| 85610 |
|
91 |
68 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
53 |
53 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$0.00 |
| 83540 |
|
31 |
31 |
$0.00 |
| 77062 |
|
41 |
41 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$0.00 |
| 81003 |
|
12 |
12 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
12 |
12 |
$0.00 |
| 3046F |
|
52 |
51 |
$0.00 |
| 90750 |
|
13 |
13 |
$0.00 |
| 1033F |
|
33 |
33 |
$0.00 |
| 3051F |
|
25 |
24 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,085 |
1,980 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,460 |
1,359 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
190 |
188 |
$0.00 |
| 90656 |
|
62 |
62 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,500 |
1,488 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,398 |
1,300 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
314 |
308 |
$0.00 |
| 85027 |
|
852 |
824 |
$0.00 |
| 82043 |
|
387 |
379 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,719 |
2,703 |
$0.00 |
| 86780 |
|
97 |
97 |
$0.00 |
| 86592 |
|
15 |
15 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
5,534 |
4,845 |
$0.00 |
| 82728 |
|
55 |
55 |
$0.00 |
| 3079F |
|
146 |
139 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
880 |
867 |
$0.00 |
| 81001 |
|
136 |
128 |
$0.00 |
| 3074F |
|
651 |
594 |
$0.00 |
| 83735 |
|
146 |
128 |
$0.00 |
| 1220F |
|
175 |
174 |
$0.00 |
| 3044F |
|
378 |
376 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
41 |
40 |
$0.00 |
| 90686 |
|
89 |
89 |
$0.00 |
| 3075F |
|
173 |
170 |
$0.00 |
| 1111F |
|
203 |
191 |
$0.00 |
| 99443 |
|
118 |
116 |
$0.00 |
| 82607 |
|
42 |
42 |
$0.00 |
| 82746 |
|
63 |
63 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
13 |
$0.00 |
| 97010 |
|
48 |
29 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
119 |
119 |
$0.00 |
| 85652 |
|
13 |
13 |
$0.00 |
| 83550 |
|
25 |
25 |
$0.00 |
| 87340 |
|
25 |
25 |
$0.00 |
| 99441 |
|
25 |
25 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
26 |
24 |
$0.00 |